Fresh Stock’s News Report: Vale S.A. (NYSE:VALEL, Boston Scientific Corporation (NYSE:BSX)

On Wednesday, Shares of Vale S.A. (NYSE:VALE), added 9.24% and closed at $3.43. The last trading range of the stock ranges between $3.25 3.45. Trading volume recorded for this company is about 4.69 million shares as contrast to its average volume of 22.31 million shares. The share price plunged almost -9.89% in the last one month while its 52 week high is $9.14. The company has the total of 3.19 billion outstanding shares right now, while its market capitalization is about $15.53 billion.

The company has price-to-cash ratio of 3.46 and EPS ratio of -0.74. The company net profit margin is -10.40% and gross profit margin is 22.60%. Analyst recommendation for this stock stands at 3.80.

On other hand, Shares of Boston Scientific Corporation (NYSE:BSX), ended its last trade with 1.35% gain, and closed at $18.74. The average volume of the company is at 9,733,270 shares. The EPS of the company stands at $-0.30.

Boston Scientific Corporation is planned to take part in the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 in San Francisco.

Mike Mahoney, president and chief executive officer, will present at about 8:30 a.m. PT. Following a 5-minute break, Mike will be joined by Dan Brennan, executive vice president and chief financial officer, and Keith Dawkins, M.D., global chief medical officer in a question-and-answer session with audience members.


This article is published by The content included in this article is just for informational purposes only. takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.

Neither nor any of partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.

Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by

Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.

About Travis Garlick 1791 Articles
Been writing about and trading stocks since 2013. Manage a group of micro-cap investors on Facebook with over 15,000 members. Turned $8,500 into 185k the first year I started trading stocks and haven't looked back.